Anchiano Therapeutics

Form F-1/A

Anchiano Therapeutics Ltd. filed this Form F-1/A on 02/11/2019

Document Outline:

PDF Amendment no. 4 to form F-1 (LINK)

Exhibit 3.2 (LINK) 

Exhibit 4.3 (LINK) 

Exhibit 5.1 (LINK) 

Exhibit 5.2 (LINK) 

Exhibit 10.1 (LINK) 

Exhibit 23.1 (LINK) 

Complete text submission file (LINK) 

 

 

Link to PR

NASDAQ: CMMB

 

Website Terms and Conditions of Use

View/Download 

Contact

Investor Relations:

Irina Koffler LifeSci Advisors, LLC

Email: ir@chemomab.com

Phone: +1-917-734-7387

 

Chemomab Therapeutics:

Sharon Elkobi VP, Business Development

Email: bd@chemomab.com

Phone: +972773310156

 

Anchiano Therapeutics © 2021